ARTHEx Biotech clinical stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs announces closing EUR 42M Series B financing round led by Columbus Venture Partners
Source link
ARTHEx Biotech Announces EUR 42M Series B Financing
-